Skip to main content
Top
Published in: Nutrition Journal 1/2004

Open Access 01-12-2004 | Research

Randomized comparison of the effects of the vitamin D3adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients

Authors: Reinhold Vieth, Samantha Kimball, Amanda Hu, Paul G Walfish

Published in: Nutrition Journal | Issue 1/2004

Login to get access

Abstract

Background

For adults, vitamin D intake of 100 mcg (4000 IU)/day is physiologic and safe. The adequate intake (AI) for older adults is 15 mcg (600 IU)/day, but there has been no report focusing on use of this dose.

Methods

We compared effects of these doses on biochemical responses and sense of wellbeing in a blinded, randomized trial. In Study 1, 64 outpatients (recruited if summer 2001 25(OH)D <61 nmol/L) were given 15 or 100 mcg/day vitamin D in December 2001. Biochemical responses were followed at subsequent visits that were part of clinical care; 37 patients completed a wellbeing questionnaire in December 2001 and February 2002. Subjects for Study 2 were recruited if their 25(OH)D was <51 nmol/L in summer 2001. 66 outpatients were given vitamin D; 51 completed a wellbeing questionnaire in both December 2002 and February 2003.

Results

In Study 1, basal summer 25-hydroxyvitamin D [25(OH)D] averaged 48 ± 9 (SD) nmol/L. Supplementation for more than 6 months produced mean 25(OH)D levels of 79 ± 30 nmol/L for the 15 mcg/day group, and 112 ± 41 nmol/L for the 100 mcg/day group. Both doses lowered plasma parathyroid hormone with no effect on plasma calcium. Between December and February, wellbeing score improved more for the 100-mcg/day group than for the lower-dosed group (1-tail Mann-Whitney p = 0.036). In Study 2, 25(OH)D averaged 39 ± 9 nmol/L, and winter wellbeing scores improved with both doses of vitamin D (two-tail p < 0.001).

Conclusion

The highest AI for vitamin D brought summertime 25(OH)D to >40 nmol/L, lowered PTH, and its use was associated with improved wellbeing. The 100 mcg/day dose produced greater responses. Since it was ethically necessary to provide a meaningful dose of vitamin D to these insufficient patients, we cannot rule out a placebo wellbeing response, particularly for those on the lower dose. This work confirms the safety and efficacy of both 15 and 100 mcg/day vitamin D3 in patients who needed additional vitamin D.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dawson-Hughes B, Heaney R, Lips P, Meunier P, Vieth R: Vitamin D Round Table. Nutritional Aspects of Osteoporosis. Edited by: Dawson-HughesB, HeaneyR and BurckhardtP. 2004, New York, Academic Press, In press Dawson-Hughes B, Heaney R, Lips P, Meunier P, Vieth R: Vitamin D Round Table. Nutritional Aspects of Osteoporosis. Edited by: Dawson-HughesB, HeaneyR and BurckhardtP. 2004, New York, Academic Press, In press
2.
go back to reference Yates AA: Process and development of dietary reference intakes: basis, need, and application of recommended dietary allowances. Nutr Rev. 1998, 56: S5-S9.CrossRefPubMed Yates AA: Process and development of dietary reference intakes: basis, need, and application of recommended dietary allowances. Nutr Rev. 1998, 56: S5-S9.CrossRefPubMed
3.
go back to reference Intakes. Standing Committee on the Scientific Evaluation of Dietary Reference: Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D, and fluoride. 1997, National Academy Press Intakes. Standing Committee on the Scientific Evaluation of Dietary Reference: Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D, and fluoride. 1997, National Academy Press
4.
go back to reference Vieth R, Fraser D: Vitamin D insufficiency: no recommended dietary allowance exists for this nutrient. CMAJ. 2002, 166: 1541-1542.PubMedPubMedCentral Vieth R, Fraser D: Vitamin D insufficiency: no recommended dietary allowance exists for this nutrient. CMAJ. 2002, 166: 1541-1542.PubMedPubMedCentral
5.
go back to reference Vieth R, Chan PC, MacFarlane GD: Efficacy and safety of vitamin D(3) intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001, 73: 288-294.PubMed Vieth R, Chan PC, MacFarlane GD: Efficacy and safety of vitamin D(3) intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001, 73: 288-294.PubMed
6.
go back to reference Barger-Lux MJ, Heaney RP: Effects of above average summer sun exposure on serum 25-hydroxyvitamin d and calcium absorption. J Clin Endocrinol Metab. 2002, 87: 4952-4956. 10.1210/jc.2002-020636.CrossRefPubMed Barger-Lux MJ, Heaney RP: Effects of above average summer sun exposure on serum 25-hydroxyvitamin d and calcium absorption. J Clin Endocrinol Metab. 2002, 87: 4952-4956. 10.1210/jc.2002-020636.CrossRefPubMed
7.
go back to reference Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003, 77: 204-210.PubMed Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003, 77: 204-210.PubMed
8.
go back to reference Vieth R, Ladak Y, Walfish PG: Age-Related Changes in the 25-Hydroxyvitamin D Versus Parathyroid Hormone Relationship Suggest a Different Reason Why Older Adults Require More Vitamin D. J Clin Endocrinol Metab. 2003, 88: 185-191. 10.1210/jc.2002-021064.CrossRefPubMed Vieth R, Ladak Y, Walfish PG: Age-Related Changes in the 25-Hydroxyvitamin D Versus Parathyroid Hormone Relationship Suggest a Different Reason Why Older Adults Require More Vitamin D. J Clin Endocrinol Metab. 2003, 88: 185-191. 10.1210/jc.2002-021064.CrossRefPubMed
9.
go back to reference Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y: Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001, 904: 67-75. 10.1016/S0006-8993(01)02450-7.CrossRefPubMed Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y: Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001, 904: 67-75. 10.1016/S0006-8993(01)02450-7.CrossRefPubMed
10.
go back to reference Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M: Extrarenal Expression of 25-Hydroxyvitamin D(3)-1alpha-Hydroxylase. J Clin Endocrinol Metab. 2001, 86: 888-894. 10.1210/jc.86.2.888.PubMed Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M: Extrarenal Expression of 25-Hydroxyvitamin D(3)-1alpha-Hydroxylase. J Clin Endocrinol Metab. 2001, 86: 888-894. 10.1210/jc.86.2.888.PubMed
11.
go back to reference Langub MC, Herman JP, Malluche HH, Koszewski NJ: Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience. 2001, 104: 49-56. 10.1016/S0306-4522(01)00049-5.CrossRefPubMed Langub MC, Herman JP, Malluche HH, Koszewski NJ: Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience. 2001, 104: 49-56. 10.1016/S0306-4522(01)00049-5.CrossRefPubMed
12.
go back to reference Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F: Vitamin D3 and brain development. Neuroscience. 2003, 118: 641-653. 10.1016/S0306-4522(03)00040-X.CrossRefPubMed Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F: Vitamin D3 and brain development. Neuroscience. 2003, 118: 641-653. 10.1016/S0306-4522(03)00040-X.CrossRefPubMed
13.
go back to reference Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D: New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002, 13: 100-105. 10.1016/S1043-2760(01)00547-1.CrossRefPubMed Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D: New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002, 13: 100-105. 10.1016/S1043-2760(01)00547-1.CrossRefPubMed
14.
go back to reference Deldin PJ, Duncan CC, Miller GA: Season, gender, and P300. Biol Psychol. 1994, 39: 15-28. 10.1016/0301-0511(94)90054-X.CrossRefPubMed Deldin PJ, Duncan CC, Miller GA: Season, gender, and P300. Biol Psychol. 1994, 39: 15-28. 10.1016/0301-0511(94)90054-X.CrossRefPubMed
15.
go back to reference Gloth FM,III, Alam W, Hollis B: Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999, 3: 5-7.PubMed Gloth FM,III, Alam W, Hollis B: Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999, 3: 5-7.PubMed
16.
go back to reference Lansdowne AT, Provost SC: Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl). 1998, 135: 319-323. 10.1007/s002130050517.CrossRef Lansdowne AT, Provost SC: Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl). 1998, 135: 319-323. 10.1007/s002130050517.CrossRef
17.
go back to reference Van Veldhuizen PJ, Taylor SA, Williamson S, Drees BM: Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. J Urol. 2000, 163: 187-190.CrossRefPubMed Van Veldhuizen PJ, Taylor SA, Williamson S, Drees BM: Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. J Urol. 2000, 163: 187-190.CrossRefPubMed
18.
go back to reference Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003, 326: 469-475. 10.1136/bmj.326.7387.469.CrossRefPubMedPubMedCentral Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003, 326: 469-475. 10.1136/bmj.326.7387.469.CrossRefPubMedPubMedCentral
19.
go back to reference Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA: Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc. 2003, 51: 1762-1767. 10.1046/j.1532-5415.2003.51561.x.CrossRefPubMed Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA: Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc. 2003, 51: 1762-1767. 10.1046/j.1532-5415.2003.51561.x.CrossRefPubMed
20.
go back to reference Harris S, Dawson-Hughes B: Seasonal mood changes in 250 normal women. Psychiatry Res. 1993, 49: 77-87. 10.1016/0165-1781(93)90031-B.CrossRefPubMed Harris S, Dawson-Hughes B: Seasonal mood changes in 250 normal women. Psychiatry Res. 1993, 49: 77-87. 10.1016/0165-1781(93)90031-B.CrossRefPubMed
21.
go back to reference Chin A.Paw MJ, de Jong N, Schouten EG, van Staveren WA, Kok FJ: Physical exercise or micronutrient supplementation for the wellbeing of the frail elderly? A randomised controlled trial. Br J Sports Med. 2002, 36: 126-131. 10.1136/bjsm.36.2.126.CrossRefPubMedCentral Chin A.Paw MJ, de Jong N, Schouten EG, van Staveren WA, Kok FJ: Physical exercise or micronutrient supplementation for the wellbeing of the frail elderly? A randomised controlled trial. Br J Sports Med. 2002, 36: 126-131. 10.1136/bjsm.36.2.126.CrossRefPubMedCentral
22.
go back to reference Plotnikoff GA, Quigley JM: Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003, 78: 1463-1470.CrossRefPubMed Plotnikoff GA, Quigley JM: Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003, 78: 1463-1470.CrossRefPubMed
23.
go back to reference Al Faraj S, Al Mutairi K: Vitamin d deficiency and chronic low back pain in saudi arabia. Spine. 2003, 28: 177-179. 10.1097/00007632-200301150-00015.CrossRefPubMed Al Faraj S, Al Mutairi K: Vitamin d deficiency and chronic low back pain in saudi arabia. Spine. 2003, 28: 177-179. 10.1097/00007632-200301150-00015.CrossRefPubMed
24.
go back to reference Mersch PP, Middendorp HM, Bouhuys AL, Beersma DG, van den Hoofdakker RH: Seasonal affective disorder and latitude: a review of the literature. J Affect Disord. 1999, 53: 35-48. 10.1016/S0165-0327(98)00097-4.CrossRefPubMed Mersch PP, Middendorp HM, Bouhuys AL, Beersma DG, van den Hoofdakker RH: Seasonal affective disorder and latitude: a review of the literature. J Affect Disord. 1999, 53: 35-48. 10.1016/S0165-0327(98)00097-4.CrossRefPubMed
25.
go back to reference Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA: Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr. 2001, 55: 1091-1097. 10.1038/sj.ejcn.1601275.CrossRefPubMed Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA: Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr. 2001, 55: 1091-1097. 10.1038/sj.ejcn.1601275.CrossRefPubMed
26.
go back to reference Scharla SH: Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int. 1998, 8 Suppl 2: S7-12.CrossRefPubMed Scharla SH: Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int. 1998, 8 Suppl 2: S7-12.CrossRefPubMed
27.
go back to reference Trang H, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998, 68: 854-848.PubMed Trang H, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998, 68: 854-848.PubMed
28.
go back to reference Liu BA, Gordon M, Labranche JM, Murray TM, Vieth R, Shear NH: Seasonal prevalence of vitamin D deficiency in institutionalized older adults. J Am Geriatr Soc. 1997, 45: 598-603.CrossRefPubMed Liu BA, Gordon M, Labranche JM, Murray TM, Vieth R, Shear NH: Seasonal prevalence of vitamin D deficiency in institutionalized older adults. J Am Geriatr Soc. 1997, 45: 598-603.CrossRefPubMed
29.
go back to reference Vieth R, Carter G: Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitamin D. Eur J Clin Nutr. 2001, 55: 221-222. 10.1038/sj.ejcn.1601145.CrossRefPubMed Vieth R, Carter G: Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitamin D. Eur J Clin Nutr. 2001, 55: 221-222. 10.1038/sj.ejcn.1601145.CrossRefPubMed
30.
go back to reference Hollis BW, Kilbo T: The assay of circulating 1,25(OH)2D using non-end-capped C18 silica: performance and validation. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Edited by: NormanAW, SchaeferK, GrigoleitH-G and vHerrathD. 1988, Berlin, W deGruyter, 710-719. Hollis BW, Kilbo T: The assay of circulating 1,25(OH)2D using non-end-capped C18 silica: performance and validation. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Edited by: NormanAW, SchaeferK, GrigoleitH-G and vHerrathD. 1988, Berlin, W deGruyter, 710-719.
31.
go back to reference Thompson C, Cowan A: The Seasonal Health Questionnaire: a preliminary validation of a new instrument to screen for seasonal affective disorder. J Affect Disord. 2001, 64: 89-98. 10.1016/S0165-0327(00)00208-1.CrossRefPubMed Thompson C, Cowan A: The Seasonal Health Questionnaire: a preliminary validation of a new instrument to screen for seasonal affective disorder. J Affect Disord. 2001, 64: 89-98. 10.1016/S0165-0327(00)00208-1.CrossRefPubMed
33.
go back to reference Visser M, Deeg DJ, Lips P: Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003, 88: 5766-5772. 10.1210/jc.2003-030604.CrossRefPubMed Visser M, Deeg DJ, Lips P: Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003, 88: 5766-5772. 10.1210/jc.2003-030604.CrossRefPubMed
34.
go back to reference Brody BA, Dickey N, Ellenberg SS, Heaney RP, Levine RJ, O'Brien RL, Purtilo RB, Weijer C: Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?. J Bone Miner Res. 2003, 18: 1105-1109.CrossRefPubMed Brody BA, Dickey N, Ellenberg SS, Heaney RP, Levine RJ, O'Brien RL, Purtilo RB, Weijer C: Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?. J Bone Miner Res. 2003, 18: 1105-1109.CrossRefPubMed
35.
go back to reference Heaney RP: Ethical issues in the design of osteoporosis clinical trials: the state of the question. J Bone Miner Res. 2003, 18: 1117-1120.CrossRefPubMed Heaney RP: Ethical issues in the design of osteoporosis clinical trials: the state of the question. J Bone Miner Res. 2003, 18: 1117-1120.CrossRefPubMed
36.
go back to reference Harris SS, Dawson-Hughes B: Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. J Am Coll Nutr. 2002, 21: 357-362.CrossRefPubMed Harris SS, Dawson-Hughes B: Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. J Am Coll Nutr. 2002, 21: 357-362.CrossRefPubMed
37.
go back to reference Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999, 69: 842-856.PubMed Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999, 69: 842-856.PubMed
38.
go back to reference Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R: Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002, 324: 1417-10.1136/bmj.324.7351.1417.CrossRefPubMedPubMedCentral Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R: Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002, 324: 1417-10.1136/bmj.324.7351.1417.CrossRefPubMedPubMedCentral
39.
go back to reference Schade CP, Jones E.R.,Jr., Wittlin BJ: A ten-year review of the validity and clinical utility of depression screening. Psychiatr Serv. 1998, 49: 55-61.CrossRefPubMed Schade CP, Jones E.R.,Jr., Wittlin BJ: A ten-year review of the validity and clinical utility of depression screening. Psychiatr Serv. 1998, 49: 55-61.CrossRefPubMed
Metadata
Title
Randomized comparison of the effects of the vitamin D3adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients
Authors
Reinhold Vieth
Samantha Kimball
Amanda Hu
Paul G Walfish
Publication date
01-12-2004
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2004
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-3-8

Other articles of this Issue 1/2004

Nutrition Journal 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.